| |
| |
|
| Insider
Information: |
Leung Sandra |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
348,885 |
|
|
Indirect Shares
|
100,721 |
|
|
| Direct
Value |
$15,653,168 |
|
|
|
Indirect Value
|
$4,538,488 |
|
|
| Total
Shares |
449,606 |
|
|
| Total
Value |
$20,191,656 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 7.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2003-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(336) |
1,957 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2004-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
3,624 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2004-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(304) |
3,320 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
4,987 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Vice President and Secretary |
• – – |
2005-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,987 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2007-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(340) |
14,046 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,875 |
16,727 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,546) |
38,722 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,483 |
61,268 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,400 |
42,122 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
76,455 |
115,595 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(31,474) |
84,121 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,354 |
91,475 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,524) |
88,220 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
269 |
91,744 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,980 |
92,200 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,400 |
93,760 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,417 |
99,605 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,009 |
101,614 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,357 |
107,911 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,355 |
105,554 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
109,185 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,980 |
111,429 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
53,389 |
163,376 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,793 |
146,271 |
0 |
- |
|
133 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
